绝经与HIV感染女性的免疫激活相关
在350名HIV感染女性中,跨越≤2年的674人次访视测量肠屏障功能障碍、先天免疫激活和全身炎症的血浆生物标志物。绝经(末次月经后)与较高的sCD14和sCD163相关,但与IFAB、IL-6或TNFR1无关。绝经过渡期sCD14每年增加250.71 ng/mL。
要点
- 绝经状态与HIV感染女性较高的sCD14和sCD163相关。
- 绝经过渡期sCD14每年增加250.71 ng/mL(95%CI 16.63-484.79;P=.04)。
- 绝经与肠屏障功能障碍标志物IFAB及炎症标志物IL-6、TNFR1无关。
核心结论
- 在HIV感染女性中,绝经可能增加先天免疫激活,但数据不支持其对肠屏障或炎症的影响。
研究设计与样本
- 来自Women's Interagency HIV Study的350名HIV感染女性,在≤2年内共674人次访视,测量血浆生物标志物。
主要发现
- 绝经(绝经后 vs 绝经前)与较高的血浆sCD14相关(β=161.89 ng/mL;95%CI 18.37-305.41)。
- 绝经与较高的血浆sCD163相关(β=65.48 ng/mL;95%CI 6.64-124.33)。
- 绝经与血浆IFAB、IL-6或TNFR1无关。
- 在绝经过渡期,sCD14每年增加250.71 ng/mL(95%CI 16.63-484.79;P=.04),绝经前和绝经后阶段无此变化。
临床怎么用
- 对HIV感染女性,绝经过渡期可考虑监测先天免疫激活标志物如sCD14。
局限性
- 绝经过渡期免疫激活的临床意义需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persistent immune activation due to gut barrier dysfunction is a suspected cause of morbidity in HIV, but the impact of menopause on this pathway is unknown. METHODS: In 350 women with HIV from the Women's Interagency HIV Study, plasma biomarkers of gut barrier dysfunction (intestinal fatty acid binding protein; IFAB), innate immune activation (soluble CD14 and CD163; sCD14, sCD163), and systemic inflammation (interleukin-6 and tumor necrosis factor receptor 1; IL-6, TNFR1) were measured at 674 person-visits spanning ≤2 years. RESULTS: Menopause (post- vs premenopausal status) was associated with higher plasma sCD14 and sCD163 in linear mixed-effects regression adjusting for age and other covariates (β = 161.89 ng/mL; 95% confidence interval [CI], 18.37-305.41 and 65.48 ng/mL, 95% CI, 6.64-124.33, respectively); but not with plasma IFAB, IL-6, or TNFR1. In piece-wise linear mixed-effects regression of biomarkers on years before/after the final menstrual period, sCD14 increased during the menopausal transition by 250.71 ng/mL per year (95% CI, 16.63-484.79; P = .04), but not in premenopausal or postmenopausal periods. CONCLUSIONS: In women with HIV, menopause may increase innate immune activation, but data did not support an influence on the gut barrier or inflammation. Clinical implications of immune activation during menopausal transition warrant further investigation.
引用
- Peters BA, Xue X, Sheira LA, et al. Menopause Is Associated With Immune Activation in Women With HIV. J Infect Dis. 2022. PMID: 34174074. doi:10.1093/infdis/jiab341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。